Technetium-99 methylene diphosphonate - Chengdu Yunke Pharmaceuticals

Drug Profile

Technetium-99 methylene diphosphonate - Chengdu Yunke Pharmaceuticals

Alternative Names: 99 tc MDP; Tc99 MDP; Technetium-99 conjugated with methylene diphosphonate; Technetium[99Tc] Methylenediphosphonate; YunKe

Latest Information Update: 03 May 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Chengdu Yunke Pharmaceutical
  • Class Anti-inflammatories; Heavy metals; Imaging agents; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Cytokine inhibitors; Immunomodulators; Osteoclast inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Rheumatoid arthritis

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top